1. Home
  2. STKH vs TOVX Comparison

STKH vs TOVX Comparison

Compare STKH & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • TOVX
  • Stock Information
  • Founded
  • STKH 2018
  • TOVX 2001
  • Country
  • STKH Israel
  • TOVX United States
  • Employees
  • STKH N/A
  • TOVX N/A
  • Industry
  • STKH Packaged Foods
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • TOVX Health Care
  • Exchange
  • STKH Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • STKH 4.6M
  • TOVX 4.7M
  • IPO Year
  • STKH 2021
  • TOVX 2006
  • Fundamental
  • Price
  • STKH $1.55
  • TOVX $1.55
  • Analyst Decision
  • STKH
  • TOVX Strong Buy
  • Analyst Count
  • STKH 0
  • TOVX 1
  • Target Price
  • STKH N/A
  • TOVX $6.00
  • AVG Volume (30 Days)
  • STKH 28.0K
  • TOVX 136.3K
  • Earning Date
  • STKH 08-30-2024
  • TOVX 03-24-2025
  • Dividend Yield
  • STKH N/A
  • TOVX N/A
  • EPS Growth
  • STKH N/A
  • TOVX N/A
  • EPS
  • STKH N/A
  • TOVX N/A
  • Revenue
  • STKH N/A
  • TOVX N/A
  • Revenue This Year
  • STKH N/A
  • TOVX N/A
  • Revenue Next Year
  • STKH N/A
  • TOVX N/A
  • P/E Ratio
  • STKH N/A
  • TOVX N/A
  • Revenue Growth
  • STKH N/A
  • TOVX N/A
  • 52 Week Low
  • STKH $1.40
  • TOVX $1.14
  • 52 Week High
  • STKH $6.90
  • TOVX $17.00
  • Technical
  • Relative Strength Index (RSI)
  • STKH 45.54
  • TOVX 52.70
  • Support Level
  • STKH $1.40
  • TOVX $1.54
  • Resistance Level
  • STKH $1.68
  • TOVX $1.75
  • Average True Range (ATR)
  • STKH 0.14
  • TOVX 0.13
  • MACD
  • STKH 0.01
  • TOVX 0.02
  • Stochastic Oscillator
  • STKH 53.57
  • TOVX 66.67

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: